Biogen Inc.: New Data at ECTRIMS 2021 Highlight Biogen's Foc

Full analysis of Phase 3b NOVA study provides insights on efficacy of every six-week dosing with natalizumab as compared to the approved every four-week dosingReal-world analysis shows significantly lower

Related Keywords

Italy , United States , Cambridge , Cambridgeshire , United Kingdom , Italian , American , John Foley , Maha Radhakrishnan , Charles Weissmann , Walter Gilbert , Heinz Schaller , Zhovtis Ryerson , Ashleigh Koss , Robert Naismith , Mike Hencke , Kenneth Murray , American Academy Of Neurology Virtual Annual Meeting , Program Database , Linkedin , Twitter , Washington University School Of Medicine , Nasdaq , Exchange Commission , Youtube , Commitment To Health Prescribing Program , European Union , Facebook , Research In Multiple Sclerosis , European Committee For Treatment , European Committee , Multiple Sclerosis , Chief Medical Officer , Secondary Endpoints , Exploratory Outcomes , Include Evaluation , Disease Activity , Rocky Mountain , Unified Commitment , Prescribing Program , Results Suggest Consistent , Dose Titration May Prevent Delays , Reaching Maintenance , Washington University School , Presentations Featured , Randomised Controlled Study , Week Dosing , Natalizumab Versus Continued , Week Treatment , Hospitalisation Rates , Dose Titration , Gastrointestinal Tolerability , Diroximel Fumarate Versus Dimethyl , Important Safety Information , Boxed Warning , Prescribing Information , Medication Guidefor , Important Safety Informationand , Patient Informationfor , Nobel Prize , Today Biogen , Private Securities Litigation Reform Act , Neurol Neurosurg , Clinical Outcomes , Natalizumab Patients Switching , Week Dosing Versus Remaining , Radiologic Outcomes , Natalizumab Patients , Extended Interval Dosing Compared , Standard Interval Dosing , American Academy , Neurology Virtual Annual Meeting , Extended Interval Dosing , Reduced Risk , Progressive Multifocal Leukoencephalopathy , Updated Analysis , Biogen , Data , Actrims , 021 , Highlight , Focus , Patient , Entered , Outcomes , Improving , Experience ,